Back

Cyanine dye conjugates of a 2'-deoxycytidine-based auto- and mitophagy activator extend Caenorhabditis elegans lifespan

Guseva, E. A.; Kamzeeva, P. N.; Sokolskaya, S. Y.; Myasnikov, B. P.; Golubeva, J. A.; Alferova, V. A.; Zaranaina, R.-L.; Vays, V. B.; Vangeli, I. M.; Belyaev, E. S.; Potapova, O. A.; Gotmanova, N. N.; Bacheva, A. V.; Bakeeva, L. E.; Marusich, E. I.; Rubtsova, M. P.; Dontsova, O. A.; Sergiev, P. V.; Aralov, A. V.

2026-01-25 pharmacology and toxicology
10.64898/2026.01.23.701232 bioRxiv
Show abstract

BackgroundAutophagy and mitophagy are essential for cellular homeostasis and play key roles in longevity and healthy aging, whereas their age-associated decline contributes to the development of age-related diseases. The identification of small-molecule activators of these pathways therefore represents an important therapeutic objective. MethodsIn this study, we investigated a series of compounds based on a 2'-deoxycitidine-derived scaffold and systematically analyzed the impact of structural substitutions on their ability to induce autophagy and mitophagy. Chemical optimization and functional assays were combined with pathway analysis, cellular readouts of proteostasis, and in vivo lifespan assessment in Caenorhabditis elegans. ResultsThe lead compound enhanced autophagy predominantly via activation of the AMPK-ULK1 signaling pathway and induced mitophagy in a Parkin-independent manner. It promoted autophagosome formation and facilitated functional clearance of aggregation-prone mutant huntingtin. Conjugation of the lead compound with the mitochondria-targeting Cy5 dye further potentiated mitophagy induction, likely through preferential mitochondrial accumulation, while reducing cytotoxicity. Importantly, the conjugated compound significantly extended C. elegans lifespan at lower concentrations compared with the unconjugated analogue. ConclusionsTogether, these results identify a promising chemical scaffold for the development of auto-and mitophagy activators and validate mitochondria-targeted conjugation as an effective strategy to enhance their biological performance. The demonstrated in vivo efficacy supports the potential relevance of these compounds for interventions aimed at preserving proteostasis and mitochondrial quality control, with possible implications for geroprotective applications.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
npj Aging
15 papers in training set
Top 0.1%
23.1%
2
The Journals of Gerontology: Series A
25 papers in training set
Top 0.1%
10.4%
3
Aging Cell
144 papers in training set
Top 0.7%
8.6%
4
PLOS ONE
4510 papers in training set
Top 34%
4.3%
5
Scientific Reports
3102 papers in training set
Top 30%
4.1%
50% of probability mass above
6
GeroScience
97 papers in training set
Top 0.5%
3.8%
7
Biomedicine & Pharmacotherapy
43 papers in training set
Top 0.2%
2.1%
8
The Journal of Prevention of Alzheimer's Disease
10 papers in training set
Top 0.1%
2.1%
9
Aging
69 papers in training set
Top 1%
1.9%
10
Journal of Medicinal Chemistry
68 papers in training set
Top 0.5%
1.9%
11
International Journal of Biological Macromolecules
65 papers in training set
Top 1%
1.9%
12
Alzheimer's Research & Therapy
52 papers in training set
Top 1%
1.7%
13
Redox Biology
64 papers in training set
Top 0.4%
1.7%
14
Frontiers in Pharmacology
100 papers in training set
Top 3%
1.4%
15
Nature Communications
4913 papers in training set
Top 54%
1.4%
16
International Journal of Molecular Sciences
453 papers in training set
Top 10%
1.3%
17
Advanced Science
249 papers in training set
Top 15%
1.1%
18
Clinical and Translational Medicine
30 papers in training set
Top 0.7%
0.9%
19
Neurotherapeutics
11 papers in training set
Top 0.4%
0.9%
20
Pharmaceuticals
33 papers in training set
Top 1%
0.8%
21
Communications Biology
886 papers in training set
Top 20%
0.8%
22
ACS Pharmacology & Translational Science
40 papers in training set
Top 0.8%
0.8%
23
Molecular Therapy
71 papers in training set
Top 3%
0.8%
24
Molecules
37 papers in training set
Top 2%
0.8%
25
eBioMedicine
130 papers in training set
Top 4%
0.8%
26
Journal of the American Chemical Society
199 papers in training set
Top 5%
0.7%
27
Journal of Translational Medicine
46 papers in training set
Top 3%
0.7%
28
Journal of Neuroinflammation
50 papers in training set
Top 1%
0.7%
29
Science Advances
1098 papers in training set
Top 32%
0.7%
30
Nucleic Acids Research
1128 papers in training set
Top 21%
0.5%